Full Text
The Full Text of this article is available as a PDF (80.0 KB).
References
- 1.Sharpe K., Karovitch A.J., Claman P., Suh K.N. Transvaginal oocyte retrieval for in vitro fertilization complicated by ovarian abscess during pregnancy. Fertil Steril. 2006;86(1):219. doi: 10.1016/j.fertnstert.2005.12.045. [DOI] [PubMed] [Google Scholar]
- 2.Matsunaga Y., Fukushima K., Nozaki M., Nakanami N., Kawano Y., Shigematsu T., Satoh S., Nakano H. A case of pregnancy complicated by the development of a tuboovarian abscess following in vitro fertilization and embryo transfer. Am J Perinatol. 2003;20(6):277–82. doi: 10.1055/s-2003-42772. [DOI] [PubMed] [Google Scholar]
- 3.Saad M., Attia L., Temime R., Kilani M., Makhlouf T., Chachia A., Koubaa A. Ovarian abscess as a complication of assisted reproduction techniques: a case report. Tunis Med. 2010;88(4):285–287. [PubMed] [Google Scholar]
- 4.Moini A., Riazi K., Amid V., Ashrafi M., Tehraninejad E., Madani T., Owj M. Endometriosis may contribute to oocyte retrieval-induced pelvic inflammatory disease: report of eight cases. J Assist Reprod Genet. 2005;22(7–8):307–309. doi: 10.1007/s10815-005-6003-2. [DOI] [PubMed] [Google Scholar]
- 5.Jakimiuk A.J., Grzybowski W., Zakrzewski J., Lewandowski P., Kozioł K. The ovarian hyperstimulation syndrome—diagnostic criteria, management procedures. Ginekol Pol. 2006;77(11):885–892. [PubMed] [Google Scholar]
- 6.Aboulghar M. Symposium: Update on prediction and management of OHSS. Prevention of OHSS. Reprod Biomed Online. 2009;19(1):33–42. doi: 10.1016/s1472-6483(10)60043-0. [DOI] [PubMed] [Google Scholar]
- 7.Chang Y., Lee J.N., Yang C.H., Hsu S.C., Tsai E.M. An unexpected quadruplet heterotopic pregnancy after bilateral salpingectomy and replacement of three embryos. Fertil Steril. 2003;80(1):218–220. doi: 10.1016/s0015-0282(03)00547-8. [DOI] [PubMed] [Google Scholar]
- 8.Chin H.Y., Chen F.P., Wang C.J., Shui L.T., Liu Y.H., Soong Y.K. Heterotopic pregnancy after in vitro fertilization-embryo transfer. Int J Gynaecol Obstet. 2004;86(3):411–416. doi: 10.1016/j.ijgo.2004.05.011. [DOI] [PubMed] [Google Scholar]
- 9.Allen V.M., Wilson R.D., Cheung A., Genetics Committee of the Society of ObstetriciansGynaecologists of Canada Pregnancy outcomes after assisted reproductive technology.[Article in English, French] J Obstet Gynaecol Can. 2006;28(3):220–250. doi: 10.1016/S1701-2163(16)32112-0. [DOI] [PubMed] [Google Scholar]
- 10.Grandone E., Colaizzo D., Vergura P., Cappucci F., Vecchione G., Bue A., Cittadini E., Margaglione M. Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation. Hum Reprod. 2004;19(8):1796–1799. doi: 10.1093/humrep/deh346. [DOI] [PubMed] [Google Scholar]
- 11.Pappo I., Lerner-Geva L., Halevy A., Olmer L., Friedler S., Raziel A., Schachter M., Ron-El R. The possible association between IVF and breast cancer incidence. Ann Surg Oncol. 2008;15(4):1048–1055. doi: 10.1245/s10434-007-9800-2. [DOI] [PubMed] [Google Scholar]
- 12.Brinton L. Long-term effects of ovulation-stimulating drugs on cancer risk. Reprod Biomed Online. 2007;15(1):38–44. doi: 10.1016/s1472-6483(10)60689-x. [DOI] [PubMed] [Google Scholar]